Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain : a journal of neurology

• Publication date

  2016-03-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/aww012PMID 26945884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclophosphamide-responsive Lgi1-related limbic encephalitis with basal ganglia hypermetabolism

  2016cited by this paper
• Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies.

  2014cited by this paper
• Neuronal Surface Antibody-Mediated Autoimmune Encephalitis

  2014cited by this paper
• Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures.

  2014cited by this paper
• VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.

  2013cited by this paper
• Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.

  2013cited by this paper
• Faciobrachial dystonic seizures arise from cortico–subcortical abnormal brain areas

  2013cited by this paper
• Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.

  2013cited by this paper
• Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

  2011cited by this paper
• A novel mutation in the HTRA1 gene causes CARASIL without alopecia

  2011cited by this paper
• Autoantibodies associated with diseases of the CNS: new developments and future challenges.

  2011cited by this paper
• Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis?

  2011cited by this paper
• Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia

  2010cited by this paper
• Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability.

  2010cited by this paper
• Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice

  2010cited by this paper
• Disruption of LGI1–linked synaptic complex causes abnormal synaptic transmission and epilepsy

  2010cited by this paper
• Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

  2010cited by this paper
• Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

  2009cited by this paper
• Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy

  2009cited by this paper
• Predominant cortical dysfunction in Guadeloupean parkinsonism.

  2008cited by this paper
• Ictal Brain Hyperperfusion Contralateral to Seizure Onset: The SPECT Mirror Image

  2006cited by this paper
• Epilepsy-Related Ligand/Receptor Complex LGI1 and ADAM22 Regulate Synaptic Transmission

  2006cited by this paper
• Dystonic Posturing Associated with Putaminal Hyperperfusion Depicted on Subtraction SPECT

  2004cited by this paper
• Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

  2004cited by this paper
• Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features

  2002cited by this paper
• Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy.

  2002cited by this paper
• The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine‐rich repeat proteins

  2002cited by this paper
• Neurophysiology of spasms.

  2001cited by this paper
• The FAB: A frontal assessment battery at bedside

  2000cited by this paper

• Characterising Executive Functioning in the Chronic Phase of Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

  2026cites this paper
• Clinical specificities and outcome of LGI1-antibody encephalitis according to age, sex and HLA

  2025cites this paper
• [Falls related to faciobrachio-crural dystonic seizures in a case of leucine-rich glioma-inactivated 1 antibody-positive encephalitis].

  2025cites this paper
• Delta/gamma band network abnormalities and enhanced phase-amplitude coupling in anti-leucine-rich glioma-inactivated 1 encephalitis.

  2025cites this paper
• Abnormal Alterations in EEG Microstates and Functional Networks in Anti-LGI1 Antibody Encephalitis

  2025cites this paper
• Striatal stimulation causing movements mimicking faciobrachial dystonic seizures.

  2025cites this paper
• 18F‐ FDG PET Reveals a Nucleus Accumbens‐Centered Metabolic Network Correlating With Clinical Severity in Anti‐LGI1 Encephalitis

  2025cites this paper
• Serum Autoantibody Titers and Neurofilament Light Chain Levels in CASPR2/LGI1 Encephalitis

  2025cites this paper
• Faciobrachial dystonic seizure can be triggered by swallowing in LGI1 encephalitis

  2025cites this paper
• Protracted Presentation of Anti‐LGI 1 Encephalitis Associated with Prostate Cancer: A Case Report

  2025cites this paper
• Altered effective connectivity in leucine-rich glioma-inactivated 1 antibody encephalitis: a spectral dynamic causal modeling study

  2025cites this paper
• Cognitive Deficits in Anti-LGI1 Encephalitis Are Linked to Immunotherapy-Resistant White Matter Network Changes

  2025cites this paper
• Subcortical shape biomarkers reveal limbic and basal ganglia damage in anti-LGI1 encephalitis

  2025cites this paper
• Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis

  2025cites this paper
• Seizure and electroencephalographic characteristics in anti-LGI1 encephalitis.

  2025cites this paper
• Autoimmune and paraneoplastic seizures.

  2024cites this paper
• Paraneoplastic movement disorder due to suspected metastatic Leiomyosarcoma of tongue: A case report

  2024cites this paper
• Biomarker Importance Analysis for Autoimmune Encephalitis with PET

  2024cites this paper
• Agrypnia excitata: a clinical biomarker of acute relapse in anti-N-methyl-D-aspartate receptor encephalitis

  2024cites this paper
• Antibodies in neurological diseases: Established, emerging, explorative

  2024cites this paper
• Premotor cortex involvement in faciobrachial dystonic seizures: A contribution from MEG-EMG study in a case of anti-LGI1 encephalitis.

  2024cites this paper
• MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis: A Systematic Review and Meta-analysis

  2024cites this paper
• Autoimmune-associated seizure disorders.

  2024cites this paper
• Seizure and movement disorder in CACNA1E developmental and epileptic encephalopathy: Two sides of the same coin or same side of two different coins?

  2024cites this paper
• The role of the human hippocampus in decision-making under uncertainty

  2024cites this paper
• Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis

  2024cites this paper
• Dynamic Contrast-enhanced MRI Quantification of Altered Vascular Permeability in Autoimmune Encephalitis.

  2024cites this paper
• Persistent cognitive deficits in anti-LGI1 encephalitis are linked to a reorganization of structural brain networks

  2024cites this paper
• Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo

  2023cites this paper
• Focus sur les encéphalites à expression psychiatrique

  2023cites this paper
• Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT

  2023cites this paper
• Diagnostic Superiority of 18F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis

  2023cites this paper
• Movement disorders in autoimmune encephalitis: an update

  2023influential citation
• A rare case of leucine-rich glioma-inactivated 1 encephalitis presenting with neurocognitive and affective symptoms in an elderly female − Case report

  2023cites this paper
• Is There a Continuum Between Acute Symptomatic Seizures Secondary to Autoimmune Encephalitis and Autoimmune-Associated Epilepsy?

  2023cites this paper
• Mesiotemporal Volumetry, Cortical Thickness, and Neuropsychological Deficits in the Long-term Course of Limbic Encephalitis

  2023cites this paper
• A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome

  2023cites this paper
• Anti-LGI1 Encephalitis Presented With Prominent Psychosis Without Loss of Consciousness

  2023cites this paper
• Anti-LGI1 encephalitis with initiating symptom of seizures in children

  2023cites this paper
• Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on 18F-FDG PET

  2023cites this paper
• In Vivo Injection of Anti-LGI1 Antibodies into the Rodent M1 Cortex and Hippocampus Is Ineffective in Inducing Seizures

  2023influential citation
• Brain Metabolic Alterations in Seropositive Autoimmune Encephalitis: An 18F-FDG PET Study

  2023cites this paper
• Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature

  2023cites this paper
• Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications.

  2022cites this paper
• Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians

  2022cites this paper
• Anti-leucine-rich glioma inactivated-1 autoimmune encephalitis: A review of diagnosis and treatment

  2022cites this paper
• Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis.

  2022cites this paper
• Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature

  2022cites this paper
• Seizure Semiology in Antibody-Associated Autoimmune Encephalitis

  2022cites this paper
• Parallel roles of neuroinflammation in feline and human epilepsies

  2022cites this paper
• Limbic encephalitis.

  2022cites this paper
• Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis

  2022cites this paper
• Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges

  2022cites this paper
• Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.

  2022cites this paper
• The Detection of Invisible Abnormal Metabolism in the FDG-PET Images of Patients With Anti-LGI1 Encephalitis by Machine Learning

  2022cites this paper
• Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies

  2022cites this paper
• Pathophysiology and Clinical Management of Autoimmune Encephalitis-Associated Seizures

  2022cites this paper
• Whole‐brain metabolic pattern analysis in patients with anti‐leucine‐rich glioma‐inactivated 1 (LGI1) encephalitis

  2022cites this paper
• Kv1.1 channels inhibition in the rat motor cortex recapitulates seizures associated with anti-LGI1 encephalitis.

  2022cites this paper
• Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.

  2022cites this paper
• Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort

  2022influential citation
• Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis

  2022cites this paper
• Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis

  2022cites this paper
• Electroclinical biomarkers of autoimmune encephalitis.

  2022cites this paper
• Shape description and volumetry of hippocampus and amygdala in temporal lobe epilepsy - A beneficial combination with a clinical perspective.

  2022cites this paper
• Altered Mental Status in the Emergency Department – When to Consider Anti-LGI-1 Encephalitis: Case Report

  2021cites this paper
• Autoimmune Encephalitis Resembling Dementia Syndromes

  2021cites this paper
• The LGI1 protein: molecular structure, physiological functions and disruption-related seizures

  2021influential citation
• Seizures in autoimmune encephalitis: specific features based on a systematic comparative study.

  2021cites this paper
• Role of LGI1 protein in synaptic transmission: From physiology to pathology.

  2021influential citation
• Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis

  2021cites this paper
• Determinants of cognition in autoimmune limbic encephalitis—A retrospective cohort study

  2021cites this paper
• Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis

  2021cites this paper
• Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis

  2021cites this paper
• Faciobrachial motor seizures: A more apt description?

  2021cites this paper
• Electrophysiological Evaluation in Identifying Unique Sleep Features Among Anti-LGI1 Encephalitis Patients During Active and Recovery Phase

  2021cites this paper
• Sleep Disturbances Associated with Neurological Autoimmunity

  2021cites this paper
• Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis

  2021cites this paper
• Recurrent seizures of autoimmune origin: emerging phenotypes

  2021cites this paper
• Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 4-year-old girl: a case report

  2021cites this paper
• Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis.

  2021cites this paper
• Cognition and psychopathology in autoimmune encephalitides: A focus on risk factors and patient outcomes

  2021cites this paper
• Autoantibodies, Encephalopathies, and Epilepsy

  2021cites this paper
• Structural network topology in limbic encephalitis is associated with amygdala enlargement, memory performance and serostatus

  2020cites this paper
• The exploration of the spectrum of motor manifestations of anti-LGI1 encephalitis beyond FBDS.

  2020cites this paper
• Associations between HLA and autoimmune neurological diseases with autoantibodies

  2020cites this paper
• Faciobrachial Dystonic Seizures: The Borderland Between Epilepsy and Movement Disorders

  2020cites this paper
• A Study of Interactions Between Memory Disorders and Epilepsy: Epileptic Seizures in Dementia, Contrasted with Transient Epileptic Amnesia

  2020cites this paper
• Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis

  2020cites this paper
• Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies

  2020cites this paper
• Etiological assessment of status epilepticus.

  2020cites this paper
• Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis

  2020influential citation
• The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis.

  2020cites this paper
• Clinical and genetic characteristics of type I sialidosis patients in mainland China

  2020cites this paper
• Fixel-based analysis links white matter characteristics, serostatus and clinical features in limbic encephalitis

  2020cites this paper
• The Clinical Value of 18F-FDG-PET in Autoimmune Encephalitis Associated With LGI1 Antibody

  2020cites this paper
• Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune‐associated epilepsy: Conceptual definitions

  2020cites this paper
• Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features

  2020cites this paper
• Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias

  2020cites this paper
• A Two-Site, Open-Label, Non-Randomized Trial Comparing Focal Electrically-Administered Seizure Therapy (FEAST) and Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy (RUL-UBP ECT).

  2020cites this paper